Your browser doesn't support javascript.
loading
Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.
Weil, C; Mehta, D; Koren, G; Pinsky, B; Samp, J C; Chodick, G; Shalev, V.
Afiliação
  • Weil C; Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Mehta D; Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA.
  • Koren G; Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA.
  • Pinsky B; Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Samp JC; Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA.
  • Chodick G; Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA.
  • Shalev V; Epidemiology and Database Research, Maccabi Healthcare Services, Tel Aviv, Israel.
J Viral Hepat ; 25(2): 144-151, 2018 02.
Article em En | MEDLINE | ID: mdl-28984012
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Hepacivirus / Resposta Viral Sustentada Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Hepacivirus / Resposta Viral Sustentada Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article